The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAS.L Regulatory News (CAS)

  • There is currently no data for CAS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B and Appendix 3Y

28 Aug 2018 07:00

RNS Number : 9349Y
Crusader Resources
28 August 2018
 

28 August 2018

 

Crusader Resources

("Company" or "Crusader")

 

Appendix 3B and Appendix 3Y

 

Crusader Resources Limited (ASX:CAS, AIM:CAS) announces that the following Appendix 3B and Appendix 3Y information has been released on the Australian Securities Exchange ("ASX"), as required under the listing rules of the ASX.

 

 

For further information, please contact:

Mr. Paul Stephen

Investor Relations

Executive Director

Office (Aus): +61 8 9320 7500

Office (Aus): +61 8 9320 7500

Email: admin@crusaderresources.com

Email: paul@crusaderresources.com

Smith & Williamson Corporate Finance Limited

Camarco

Nominated Adviser

Financial PR

Azhic Basirov / Katy Birkin / Ben Jeynes

Gordon Poole / Nick Hennis / Monique Perks

+44(0)207 131 4000

+44(0)20 3757 4997 / +44(0)20 3781 8330

Hannam & Partners

Joint Broker

Neil Passmore / Andrew Chubb / Ernie Bell

+44 (0)20 7907 8500

 

 

 

 

 

Appendix 3B

New issue announcement

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

Name of entity

Crusader Resources Limited

 

ABN

94 106 641 963

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

(a) Unlisted options lapsed

(b) Unlisted options lapsed

 

 

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

(a) 1,246,550

(b) 1,885,000

 

 

 

 

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

(a) Unlisted Options (exercisable $0.41 each, expiring 20 August 2018)

(b)Unlisted Options (exercisable $0.52 each, expiring 14 August 2018)

 

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

5

Issue price or consideration

 

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

Options lapsed

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

 

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

 

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

 

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Options lapsed 14 and 20 August 2018

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

502,150,521

Fully paid ordinary shares.

 

 

Number

+Class

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,741,258

 

 

 

 

1,000,000

 

 

 

1,000,000

 

 

 

1,000,000

 

 

 

5,000,000

 

 

 

 

5,000,000

 

 

 

75,377,144

 

 

 

17,622,977

 

 

Options exercisable at $0.286 each expiring 31 December 2018

 

Options exercisable at $0.15 each expiring 19 May 2023

 

Options exercisable at $0.20 each expiring 19 May 2023

 

Options exercisable at $0.30 each expiring 19 May 2023

 

Options exercisable at $0.195 each expiring 23 December 2019

 

Options exercisable at $0.26 each expiring 23 December 2019

 

Options exercisable at $0.055 each expiring 31 May 2020

 

Performance Rights - expire 20 Nov 2022 if vesting conditions not satisfied

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

 

12

Is the issue renounceable or non-renounceable?

 

 

13

Ratio in which the +securities will be offered

 

 

14

+Class of +securities to which the offer relates

 

 

15

+Record date to determine entitlements

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

 

 

17

Policy for deciding entitlements in relation to fractions

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

 

 

19

Closing date for receipt of acceptances or renunciations

 

20

Names of any underwriters

 

 

 

21

Amount of any underwriting fee or commission

 

 

22

Names of any brokers to the issue

 

 

23

Fee or commission payable to the broker to the issue

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 

 

28

Date rights trading will begin (if applicable)

 

 

29

Date rights trading will end (if applicable)

 

 

 

30

How do security holders sell their entitlements in full through a broker?

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

 

 

33

+Issue date

 

 

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

x

+Securities described in Part 1

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

 

 

 

 

39

+Class of +securities for which quotation is sought

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

Sign here: ........................................................... Date 27 August 2018

(Director/Company secretary)

 

 

Print name: Andrew Beigel

 

== == == == ==

 

 

Appendix 3Y

Change of Director's Interest Notice

 

 

 

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

 

Name of entity CRUSADER RESOURCES LIMITED

ABN 94 106 641 963

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director

Paul Richard Stephen

Date of last notice

29 April 2016

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

The Stephen Superfund (Trustee and Member)

Blue Bone Enterprises (WA) Pty Ltd (Shareholder)

 

 

Date of change

14 August 2018

No. of securities held prior to change

Paul Stephen

 

 

The Stephen Superfund

 

 

Blue Bone Enterprises (WA) Pty Ltd

 

458,333 Unlisted Options ($0.43, 7/8/17)

500,000 Unlisted Options ($0.52, 14/8/18)

 

2,009,495 Ordinary Shares

50,000 Unlisted Options ($0.15, 31/12/17)

 

3,068,571 Ordinary Shares

 

Class

 

 

 

Unlisted Options ($0.52, 14/8/18)

Unlisted Options ($0.43, 7/8/17)

Unlisted Options ($0.15, 31/12/17)

 

Number acquired

Nil

 

Number disposed

1,008,333 Options lapsed

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

N/A

No. of securities held after change

 

The Stephen Superfund

 

Blue Bone Enterprises (WA) Pty Ltd

 

 

2,009,495 Ordinary Shares

 

3,068,571 Ordinary Shares

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Options lapsed

 

 

 

Part 2 - Change of director's interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Detail of contract

Nature of interest

 

Name of registered holder

(if issued securities)

 

Date of change

No. and class of securities to which interest related prior to change

Interest acquired

Interest disposed

Value/Consideration

 

Interest after change

 

 

 

 

 

Part 3 - +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

 

 

Appendix 3Y

Change of Director's Interest Notice

 

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 

Name of entity Crusader Resources Limited

ABN 94 106 641 963

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director

John Richard Evans

Date of last notice

15 August 2014

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Direct or indirect interest

Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

Date of change

14 August 2018

No. of securities held prior to change

330,000 Unlisted Options ($0.52, 14/8/18)

330,000 Unlisted Options ($0.43, 7/8/17)

 

Class

Unlisted Options ($0.52, 14/8/18)

Unlisted Options ($0.43, 7/8/17)

Number acquired

N/A

Number disposed

660,000 lapsed

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

N/A

No. of securities held after change

nil

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Options lapsed

 

Part 2 - Change of director's interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Detail of contract

Nature of interest

 

 

Name of registered holder

(if issued securities)

 

Date of change

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

Interest after change

 

Part 3 - +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBDLLLVVFXBBV
Date   Source Headline
7th Mar 20199:46 amRNSInitial Director's Interest Notice - Appendix 3X
7th Mar 20199:45 amRNSStrategies for the future of Crusader
7th Mar 20199:40 amRNSFinal Director's Interest Notice - Appendix 3Z
1st Mar 201910:00 amRNSAppointment of new Directors
28th Feb 201911:00 amRNSResult of General Meeting
22nd Feb 201912:45 pmRNSAgreement on funding proposal and Board changes
22nd Feb 201911:05 amRNSResignation of Nominated Adviser
13th Feb 20197:00 amRNSSection 249D Request Notice of General Meeting
7th Feb 201911:15 amRNSHolding(s) in Company
5th Feb 201911:35 amRNSHolding(s) in Company
1st Feb 20197:00 amRNSAppendix 3Z Final Director's Interest notice
31st Jan 20198:02 amRNSQuarterly Activities Report and Appendix B
30th Jan 20197:00 amRNSProposed cancellation of Ordinary Shares on AIM
29th Jan 20197:02 amRNSCrusader Funding Update
29th Jan 20197:01 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSNotice under section 249D of the Corporations Act
23rd Jan 20197:07 amRNSCorporate Update
24th Dec 20187:00 amRNSAdditional Funding
20th Dec 20181:53 pmRNSHolding(s) in Company
11th Dec 20187:00 amRNSAppointment of Nominated Adviser and update
28th Nov 20187:00 amRNSUpdate on Posse
5th Nov 20187:02 amRNSConvertible loans fund raising
5th Nov 20187:01 amRNSOperational Update
5th Nov 20187:00 amRNSResignation of Nominated Adviser
31st Oct 20187:17 amRNSQuarterly Activities Report and Appendix 5B
30th Oct 20181:07 pmRNSDirectorate Change
29th Oct 20182:00 pmRNSPosse Update
1st Oct 20187:30 amRNSSuspension - Crusader Resources Limited
1st Oct 20187:00 amRNSSuspension of Trading
14th Sep 20187:00 amRNSInterim Results
5th Sep 20189:44 amRNSResponse to Appendix 3Y Query
28th Aug 20187:00 amRNSAppendix 3B and Appendix 3Y
20th Aug 20187:00 amRNSBorborema BFS - Metallurgical Testing
9th Aug 20187:00 amRNSResponse to Appendix 5B Query
1st Aug 20187:01 amRNSAppointment of Joint Broker
1st Aug 20187:00 amRNSQuarterly Activities Report
30th Jul 20187:00 amRNSLicensing Update - Borborema Gold Project
11th Jul 20187:00 amRNSCorporate Update
9th Jul 20183:20 pmRNSPosse Update
19th Jun 20189:00 amRNSChange of Registered Office
12th Jun 20187:00 amRNSLondon Investor Presentation Evening
8th Jun 20187:00 amRNSJuruena Gold Project Drilling Update
30th May 20187:00 amRNSResult of AGM
11th May 20187:00 amRNSCorporate Presentation
9th May 20187:07 amRNSBorborema BFS ? Commencement of Met Testing
2nd May 20181:38 pmRNSNotice of AGM
1st May 20187:00 amRNSQuarterly Activities Report - March 2018
17th Apr 20188:31 amRNSDirectorate Change
16th Apr 20187:25 amRNSFirst Day of Dealings on AIM
24th Jun 20054:31 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.